EA202090163A1 - MEANS FOR TREATMENT OF FEMALE INFERTILITY AND FEMALE ANIMALS - Google Patents

MEANS FOR TREATMENT OF FEMALE INFERTILITY AND FEMALE ANIMALS

Info

Publication number
EA202090163A1
EA202090163A1 EA202090163A EA202090163A EA202090163A1 EA 202090163 A1 EA202090163 A1 EA 202090163A1 EA 202090163 A EA202090163 A EA 202090163A EA 202090163 A EA202090163 A EA 202090163A EA 202090163 A1 EA202090163 A1 EA 202090163A1
Authority
EA
Eurasian Patent Office
Prior art keywords
female
infertility
treatment
animals
octahydroselenoxanthene
Prior art date
Application number
EA202090163A
Other languages
Russian (ru)
Inventor
Кенес Тагаевич ЕРИМБЕТОВ
Екатерина Валерьевна БОНДАРЕНКО
Елена Евгеньевна КАЛАШНИКОВА
Анна Яковлевна ГОНЧАРОВА
Рахимджан Ахметджанович РОЗИЕВ
Original Assignee
Рахимджан Ахметджанович РОЗИЕВ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рахимджан Ахметджанович РОЗИЕВ filed Critical Рахимджан Ахметджанович РОЗИЕВ
Publication of EA202090163A1 publication Critical patent/EA202090163A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к медицине и ветеринарии, а именно к медицинской и ветеринарной гинекологии. Предлагается применение 9-фенил-симм-октагидроселеноксантена в качестве средства для лечения женского бесплодия и бесплодия самок животных, стимулирующего фолликулогенез и способствующего имплантации эмбрионов в эндометрий матки. Предлагается также лекарственный препарат и фармацевтическая композиция, включающие в качестве активного компонента 9-фенил-симм-октагидроселеноксантен. Изобретение расширяет арсенал средств, способствует увеличению фертильности за счет негормонального стимулирования фолликулогенеза.The invention relates to medicine and veterinary medicine, namely to medical and veterinary gynecology. Proposed is the use of 9-phenyl-sym-octahydroselenoxanthene as a means for the treatment of female infertility and infertility in female animals, stimulating folliculogenesis and facilitating the implantation of embryos into the endometrium of the uterus. Also proposed is a drug and a pharmaceutical composition comprising 9-phenyl-sym-octahydroselenoxanthene as an active component. The invention expands the arsenal of drugs, helps to increase fertility due to non-hormonal stimulation of folliculogenesis.

EA202090163A 2017-06-28 2018-06-27 MEANS FOR TREATMENT OF FEMALE INFERTILITY AND FEMALE ANIMALS EA202090163A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2017122775A RU2740922C2 (en) 2017-06-28 2017-06-28 Agent for treating female infertility and infertility of female animals
PCT/RU2018/050068 WO2019004877A1 (en) 2017-06-28 2018-06-27 Agent for treating female infertility and infertility in female animals

Publications (1)

Publication Number Publication Date
EA202090163A1 true EA202090163A1 (en) 2020-08-17

Family

ID=64741812

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202090163A EA202090163A1 (en) 2017-06-28 2018-06-27 MEANS FOR TREATMENT OF FEMALE INFERTILITY AND FEMALE ANIMALS

Country Status (3)

Country Link
EA (1) EA202090163A1 (en)
RU (1) RU2740922C2 (en)
WO (1) WO2019004877A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2212888C2 (en) * 2001-10-26 2003-09-27 Галочкин Владимир Анатольевич Method for normalization of reproductive function in cows
RU2281007C2 (en) * 2004-12-06 2006-08-10 Геннадий Иванович Боряев Method for production of bioactive substance selenopyran, selenopyran and products containing the same
RU2317074C1 (en) * 2006-03-16 2008-02-20 Общество с ограниченной ответственностью "МБФ" Hematopoietic precursor cell differentiation inhibitor
RU2414215C1 (en) * 2009-09-24 2011-03-20 Общество С Ограниченной Ответственностью "Научно-Производственная Компания "Медбиофарм" Method of improving and/or recovery of reproductive function
RU2451680C1 (en) * 2011-02-21 2012-05-27 Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" Clatrate complex of cyclodextrine or arabinogalactane with 9-phenyl-symm-octahydroselenoxantene, its production method (versions), pharmaceutical composition and medication
RU2487705C1 (en) * 2012-03-21 2013-07-20 ОКТАПАМ Лимитед Agent for improving reproductive function

Also Published As

Publication number Publication date
WO2019004877A1 (en) 2019-01-03
RU2740922C2 (en) 2021-01-21
RU2017122775A3 (en) 2020-09-15
RU2017122775A (en) 2018-12-29

Similar Documents

Publication Publication Date Title
EA201101518A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN MEDICAL AND VETERINARY OPHTHALMOLOGY
MX2021012579A (en) Collagen peptide-based medicament compositions and devices and methods of production and use thereof.
RU2020120156A (en) TREATMENT AND LOSS OF BONE TISSUE CAUSED BY ANDROGENIC DEPRIVATION THERAPY USING CIS-CLOMIFEN
RU2015120055A (en) BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS A MEANS TO STIMULATE TISSUE REGENERATION AND RESTORATION OF DECREASED FABRIC FUNCTIONS
EA202090163A1 (en) MEANS FOR TREATMENT OF FEMALE INFERTILITY AND FEMALE ANIMALS
Lindholm et al. Comparison of deslorelin and histrelin for induction of ovulation in mares
RU2557957C1 (en) Method of treating patients with chronic endometritis and tubal and peritoneal infertility factor
Azawi et al. Misoprostol treatment of dystocia due to incomplete dilatation of the cervix in a cow: a case report
CO2022002493A2 (en) 18p-glycyrrhetinic acid nanoemulsion
RU2572216C1 (en) Method of treatment of subacute subinvolution of uterus in cows
Selig et al. Management of omphalophlebitis and umbilical hernia in three neonatal giraffe (Giraffa camelopardalis)
RU2663051C1 (en) Method for direct lymphotropic therapy in case of endometritis in cows
EA201500137A1 (en) METHOD OF TREATING ADDICTION
RU2015138087A (en) The active ingredient of the drug, drug, pharmaceutical composition and method for the treatment of demyelinating diseases of a living organism, including disease prevention
Kumar et al. Management of pre-cervical uterine torsion in a buffalo
WO2018044132A3 (en) Condom for patient with erectile dysfunction
UA95686U (en) MEDICINE FOR PREPOSITION DISEASE THERAPY IN THE SURFACE FORM
EA201900418A1 (en) MEANS FOR THERAPY OF WOUND OR BURN SKIN INJURIES
RU2366382C1 (en) Method of test boar preparing
Girod et al. Comparison of two non-invasive 2% enilconazole infusion protocols for treatment of canine sinonasal aspergillosis and importance of debridement for treatment efficacy.
RU2009116971A (en) METHOD OF STIMULATION OF GENDER AND SYNCHRONIZATION OF OVULATION IN PIGS
RU2526203C1 (en) Method of production of anti-luteolytic blood - alb, method of treatment and prevention of postpartum obstetric and gynecological diseases in cows
RU2406484C1 (en) Method of treating displaced abomasum
RU2258501C2 (en) Method for applying ethidium bromide for treatment of horses with pyroplasmosis
RU2210363C2 (en) Method for treatment of cows with post-delivery acute suppurative-catarrhal endometritis